Vasamed Inc
Vasamed, Inc. designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. It offers SensiLase PAD-IQ, which supports skin perfusion pressure, pulse volume recording, and ankle brachial index calculation for Doppler-obtained pressures; and Wound Imaging & SmartDraw wound measurement systems. The company also … Read more
Vasamed Inc (VSMD) - Total Liabilities
Latest total liabilities as of June 2009: $3.40 Million USD
Based on the latest financial reports, Vasamed Inc (VSMD) has total liabilities worth $3.40 Million USD as of June 2009.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Vasamed Inc - Total Liabilities Trend (1996–2008)
This chart illustrates how Vasamed Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Vasamed Inc Competitors by Total Liabilities
The table below lists competitors of Vasamed Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gritstone bio, Inc.
NASDAQ:GRTSQ
|
USA | $120.35 Million |
|
Transtech Industries Inc
PINK:TRTI
|
USA | $8.98 Million |
|
LEEP Inc
PINK:LPPI
|
USA | $2.71 Million |
|
Interact-TV Inc
PINK:ITVI
|
USA | $1.69 Million |
|
EcoLogix Resource Group Inc
PINK:EXRG
|
USA | $11.34 Million |
|
Kinbasha Gaming International Inc
PINK:KNBA
|
USA | $145.14 Million |
|
Café Serendipity Holdings Inc
PINK:CAFS
|
USA | $2.34 Million |
|
Southcorp Capital Inc
PINK:STHC
|
USA | $485.57K |
Liability Composition Analysis (1996–2008)
This chart breaks down Vasamed Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Vasamed Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Vasamed Inc (1996–2008)
The table below shows the annual total liabilities of Vasamed Inc from 1996 to 2008.
| Year | Total Liabilities | Change |
|---|---|---|
| 2008-12-31 | $2.76 Million | +418.34% |
| 2007-12-31 | $532.64K | -90.69% |
| 2006-12-31 | $5.72 Million | +469.38% |
| 2005-12-31 | $1.01 Million | -78.68% |
| 2004-12-31 | $4.72 Million | +672.55% |
| 2003-12-31 | $610.45K | -79.06% |
| 2002-12-31 | $2.91 Million | +23.97% |
| 2001-12-31 | $2.35 Million | +36.41% |
| 2000-12-31 | $1.72 Million | +83.13% |
| 1999-12-31 | $941.06K | -41.18% |
| 1998-12-31 | $1.60 Million | +14.29% |
| 1997-12-31 | $1.40 Million | 0.00% |
| 1996-12-31 | $1.40 Million | -- |